HBIO: Total dodolan perusahaan Harvard Bioscience

Harvard Bioscience is implementing ESG principles by reducing its carbon footprint and resource consumption in the production of medical technology. Corporate sales clearly demonstrate revenue dynamics, where 0.09 determines the current level of this parameter. Business efficiency is supported by outsourced manufacturing and logistics, while the brand's impeccable reputation among global laboratories guarantees stable demand for Harvard Bioscience products.

Harvard Bioscience, Inc. (HBIO) - Dodolan perusahaan saka 04.07.2022 nganti 13.11.2026

Rincian metrik komprehensif lan analitis Harvard Bioscience, Inc. (HBIO)

- nilai pasar lan prakiraan target analis:

Bagan bursa harvardbioscience.com|HBIO - Target konsensus

- informasi kapitalisasi pasar:

Nilai pasar Harvard Bioscience, Inc.|HBIO - Nilai Total Perusahaan

- indikator kapitalisasi buku:

Nilai Akuntansi Saham Harvard Bioscience|HBIO - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku harvardbioscience.com|HBIO - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Total Utang marang Ekuitas Harvard Bioscience|HBIO - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal Harvard Bioscience Inc.|HBIO - Utang perusahaan|Rasio utang marang nilai buku Harvard Bioscience, Inc.|HBIO - Kewajiban jangka dawa perusahaan|Gedhene kewajiban jangka cendhak Harvard Bioscience|Koefisien jangkoan perantara harvardbioscience.com

- indikator bathi lan kelipatan valuasi:

HBIO - Bathi resik|Penghasilan resik sing dikarepake Harvard Bioscience|HBIO - Pangali P/E|Pangali Forward P/E harvardbioscience.com|HBIO - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Harvard Bioscience, Inc.|HBIO - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Harvard Bioscience|HBIO - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan harvardbioscience.com|HBIO - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Harvard Bioscience

- rincian pendapatan lan dodolan emiten:

HBIO - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan Harvard Bioscience Inc.|HBIO - Kapitalisasi marang pendapatan|Rega forward marang dodolan Harvard Bioscience, Inc.

Analisis komprehensif perusahaan:harvardbioscience.com HBIO

Produk mawa merek Harvard Bioscience, Inc.

Searching for fundamentally resilient assets requires separating short-term market noise from actual operational activity. This metric captures daily trading inflows, allowing for the determination of the statistical norm of demand and eliminating the risk of overpaying for one-off spikes. For Harvard Bioscience (HBIO), this analysis confirms the effectiveness of Jim Green's strategy to refresh the product portfolio. By assessing the company's sales revenue, an investor can verify the stability of long-term margin optimization.

Perusahaan pesaing